Skip to main navigation Skip to search Skip to main content

A Phase II Study of Oral Panobinostat (LBH589) in Adult Patients with Advanced Refractory Multiple Myeloma

  • Jeffrey Lee Wolf
  • , David Siegel
  • , Jeffrey Matous
  • , Sagar Lonial
  • , Hartmut Goldschmidt
  • , Stefan Schmitt
  • , Ravi Vij
  • , Margarida De Malgalhaes-Silverman
  • , Rafat Abonour
  • , Muhammad Jalaluddin
  • , Martha Li
  • , Katharine Hazell
  • , Priscille M. Bourquelot
  • , Maria-Victoria Mateos
  • , Kenneth C. Anderson
  • , Andrew Spencer
  • , Jean-Luc Harousseau
  • , Joan Bladé
  • University of California, San Francisco
  • Hackensack University Medical Center
  • Rocky Mountain Cancer Center, Denver, CO, USA
  • Emory University
  • Nationales Centrum für Tumorerkrankungen, Heidelberg, Germany
  • University Hospital Heidelberg
  • University of Washington
  • University of Iowa
  • Indiana University
  • Novartis
  • Hospital Universitario de Salamanca, Salamanca, Spain
  • Harvard University
  • Alfred Hospital
  • Hôpital Hôtel Dieu, Nantes, France
  • Hospital Clinic, IDIBAPS, Barcelona, Spain

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalBlood
Volume112
Issue number11
DOIs
StatePublished - Nov 16 2008
Externally publishedYes

Disciplines

  • Pharmacology
  • Medicine and Health Sciences
  • Oncology
  • Internal Medicine

Cite this